Scarica l'app Stockscreener
24.44
1.77%
-0.44
Precedente Chiudi:
$24.88
Aprire:
$24.87
Volume 24 ore:
4.09M
Relative Volume:
0.83
Capitalizzazione di mercato:
$12.15B
Reddito:
$4.72B
Utile/perdita netta:
$-232.00M
Rapporto P/E:
-52.41
EPS:
-0.4663
Flusso di cassa netto:
$284.00M
1 W Prestazione:
-8.94%
1M Prestazione:
+0.16%
6M Prestazione:
+39.90%
1 anno Prestazione:
+126.30%
Intervallo 1D:
$24.41
$25.17
Intervallo di 1 settimana:
$24.41
$26.93
Portata 52W:
$8.02
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
24.44 | 12.37B | 4.72B | -232.00M | 284.00M | -0.4663 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Dimensional Fund Advisors LP Has $497.61 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Black Creek Investment Management Inc. - MarketBeat
Elanco (ELAN) EVP awarded stock, options and disposes shares for taxes - Stock Titan
Elanco (NYSE: ELAN) CEO receives large stock grants and tax share sale - Stock Titan
Elanco (ELAN) CAO reports RSU grants and tax-withholding share disposal - Stock Titan
Elanco (ELAN) executive Modi receives stock awards and delivers shares for taxes - Stock Titan
Elanco (ELAN) CFO VanHimbergen receives new stock and option grants - Stock Titan
Elanco (ELAN) executive equity awards and tax share withholding detailed - Stock Titan
ELAN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Royce & Associates LP Buys 105,632 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Agriculture Biotechnology Industry Research and Global Forecast Report 2025-2030, Profiles of Prominent PlayersBayer, Corteva Agriscience, BASF, Syngenta, Zoetis, Elanco Animal Health, Novonesis - GlobeNewswire
Elanco Animal Health (ELAN) Stock Analysis: Navigating a 8.97% Potential Upside in the Booming Animal Health Market - DirectorsTalk Interviews
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Update - MarketBeat
TD Asset Management Inc Has $21.87 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
JPMorgan Chase & Co. Buys 1,394,839 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Q4 2025 Earnings Highlights - Intellectia AI
PetMed, Elanco, Tractor Supply Settle Flea & Tick Med Claims - Law360
Elanco (ELAN) Q4 2025 Earnings Call Transcript - AOL.com
Chewy reaches settlement in Elanco flea and tick antitrust litigation - DVM360
Elanco Animal Health Q4 Loss Deepens And Tests Bullish Profitability Narratives - simplywall.st
Amlan International and Elanco Collaborate on Japanese Educational Seminars Focused on Calf Health - Yahoo Finance
Jim Cramer Highlights Elanco’s “Comeback Story” - Yahoo Finance
Primecap Management Co. CA Has $1.01 Billion Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Reports Q4 Loss and Revenue Growth - Intellectia AI
Elanco’s AHV Deal And Befrena Win Reshape Growth And Valuation Story - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC) - The Globe and Mail
Morgan Stanley Raises Price Target for Elanco Animal Health (ELA - GuruFocus
Elanco Animal Health (NYSE:ELAN) Given New $24.00 Price Target at Morgan Stanley - MarketBeat
Keybanc Raises Price Target for ELAN, Maintains Overweight Ratin - GuruFocus
Elanco Animal Health (NYSE:ELAN) Given New $29.00 Price Target at KeyCorp - MarketBeat
KeyBanc raises Elanco Animal Health price target on product strength By Investing.com - Investing.com Canada
Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2025 Earnings Call Transcript - Insider Monkey
Ameritas Investment Partners Inc. Invests $1.88 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) Surpasses Revenue Expectations and Forecasts Growt - GuruFocus
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus
Elanco (ELAN) Focuses on Growth through Innovation and Cash Flow Management - GuruFocus
Elanco (ELAN) officer granted 56.63 deferred stock units in Form 4 - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons awarded new deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CFO receives new deferred stock unit grant - Stock Titan
Elanco Animal Health Q4 Earnings Call Highlights - MarketBeat
Elanco Animal Health Inc (ELAN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
Elanco Animal Health (ELAN) Receives Outperform Rating with Rais - GuruFocus
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $30.00 at Leerink Partners - MarketBeat
Elanco Animal Health Shares Rise After Q4 Beat - marketscreener.com
Elanco Working To Enhance Tools To Address New World Screwworm - Southeast AgNET
Elanco Animal Health Incorporated Q4 2025 Earnings Call Summary - Yahoo Finance
Is Elanco Animal Health (ELAN) Still Attractive After A 123% One Year Share Price Jump - simplywall.st
Elanco (ELAN) Surges to 52-Week High on Strong Q4 Results - GuruFocus
Why Is Elanco (ELAN) Stock Soaring Today - Finviz
Elanco hits 52-week high after Q4 results as 2026 outlook beats consensus - Seeking Alpha
Elanco Animal Health (NYSE:ELAN) Sets New 52-Week High Following Earnings Beat - MarketBeat
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):